Movement-speed biofeedback to improve muscle activation and self-perception in older adults with sarcopenia
Official title: The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
Run by Creighton University · NCT06853275 · Data updated 2026-11-12
This test will see if giving older adults with sarcopenia feedback on how fast they move during leg-press exercises helps preserve movement speed, increase muscle activation, and change motivation and perceived effort.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 95 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Creighton University Academic / other |
| Locations | 1 site (Omaha, Nebraska) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT06853275 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Community-dwelling, physically independent adults aged 60–95 who are cognitively intact, score 4 or higher on the SARC-F, have not done structured resistance training in the past year, and have no recent lower-limb injury or major neuromuscular or circulatory conditions are the intended participants.
✕Probably not a fit
People with recent lower-extremity injury or surgery, active neuromuscular or circulatory disease, significant edema, severe cognitive impairment, or those already engaged in regular resistance training are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Older adults with sarcopenia will be assigned to either an external-focus group that receives real-time movement-velocity feedback or to an internal-focus control group with no cues. Participants visit the lab once per week for three weeks to perform leg-press exercise testing while researchers measure percent velocity loss and neuromuscular activation and collect questionnaires on motivation and perceived workload. Exclusion criteria include recent structured resistance training, recent lower-extremity injury or surgery, and neurologic or circulatory conditions that affect movement. The trial tests whether external velocity biofeedback changes short-term performance metrics and participants' perceived workload and motivation.
Why it matters
Potential benefit: If successful, velocity biofeedback could help therapists tailor resistance training to better maintain muscle power and motivation in older adults with sarcopenia.
How similar studies have gone: Related work on velocity-based training and movement biofeedback has shown improvements in power and motor performance in younger and general older populations, but direct evidence in sarcopenic older adults is limited, making this a relatively novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Community-dwelling older adults 60-95 years of age * Physically independent * Free of severe mental impairment * Score 4 or greater on the SARC-F sarcopenia questionnaire Exclusion Criteria: * Participated in a structured resistance training program in the last 12 months * Had a lower extremity injury or surgical intervention within the past 6 months * Have neuromuscular (i.e., Parkinson's Disease, Multiple Sclerosis), circulatory, or edema pathology
Where it's running
-
Creighton University
Omaha, Nebraska, United States Recruiting
Study contacts
- Study coordinator: Rashelle Hoffman, PT, DPT, PhD
- Email: rashellehoffman@creighton.edu
- Phone: 402-280-5691
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Volunteer-led lifestyle program to help sarcopenia in older adults
This program tests a digital, volunteer-supported lifestyle plan to improve muscle health and reduce fall risk in older adults with sarcopenia or frailty.
-
AMC6156 for older adults with sarcopenia
This trial will try once-daily AMC6156 pills or a placebo for 12 weeks to see if they improve strength and mobility in older adults with sarcopenia.
-
Effects of leucine and fatty acids on muscle health in older adults
This study is testing if adding leucine-rich protein and healthy fats to the diets of older adults can help improve their muscle health and strength.
-
Investigating protein changes in aging and muscle function
This study is trying to see how changes in muscle proteins affect strength and movement in older adults to help improve their recovery and mobility.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.